The first NGS studies of breast cancer (BC) identified only three genes mutated in more than 10 % of BC tumors: TP53 (mutation rate 40 % of tumors), PI3K (25 % of tumors), and GATA3 (10 % of tumors). This evidence concerns the gene TP53 and breast cancer.